9I9R | pdb_00009i9r

X-ray structure of the drug binding domain of AlbA in complex with the KMR-04-163 compound of the pyrrolobenzodiazepines class

PDB DOI: https://doi.org/10.2210/pdb9I9R/pdb

Classification: ANTIMICROBIAL PROTEIN
Organism(s): Klebsiella oxytoca
Expression System: Escherichia coli
Mutation(s): No

Deposited: 2025-02-06 Released: 2026-02-18
Deposition Author(s): Di Palma, M., Steiner, R.A.
Funding Organization(s): Ministero dell Universita e della Ricerca

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 2.58 Å
R-Value Free:
0.227 (Depositor), 0.219 (DCC)
R-Value Work:
0.195 (Depositor), 0.190 (DCC)
R-Value Observed:
0.197 (Depositor)

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Ligand Structure Quality Assessment

This is version 1.0 of the entry. See complete history.

Literature

X-ray structure of the drug binding domain of AlbA in complex with the KMR-04-161 compound of the pyrrolobenzodiazepines class

Di Palma, M., Steiner, R.A.

To be published.

Macromolecule Content

Total Structure Weight: 82.29 kDa
Atom Count: 5,835
Modeled Residue Count: 648
Deposited Residue Count: 672
Unique protein chains: 1

Macromolecules

Find similar proteins by:

| 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Albicidin resistance protein	A [auth C], B [auth A], C [auth B]	224	Klebsiella oxytoca	Mutation(s): 0 Gene Names: albA
UniProt
Find proteins for Q8KRS7 (Klebsiella oxytoca) Explore Q8KRS7 Go to UniProtKB: Q8KRS7
Entity Groups
Sequence Clusters	30% Identity 50% Identity 70% Identity 90% Identity 95% Identity 100% Identity
UniProt Group	Q8KRS7
Sequence Annotations Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram	3D Interactions
A1I1J (Subject of Investigation/LOI) Query on A1I1J Download:Ideal Coordinates CCD File SDF format, chain H [auth B] SDF format, chain F [auth A] SDF format, chain E [auth C] SDF format, chain D [auth C] MOL2 format, chain H [auth B] MOL2 format, chain F [auth A] MOL2 format, chain E [auth C] MOL2 format, chain D [auth C] mmCIF format, chain H [auth B] mmCIF format, chain F [auth A] mmCIF format, chain E [auth C] mmCIF format, chain D [auth C]	D [auth C], E [auth C], F [auth A], H [auth B]	4-[4-[4-[[(6~{S},6~{a}~{S})-2-methoxy-6-oxidanyl-11-oxidanylidene-5,6,6~{a},7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]phenyl]-~{N}-(1-benzothiophen-5-yl)-1-methyl-pyrrole-2-carboxamide C₃₇ H₃₇ N₅ O₆ S IYXKDRXBSVLURX-UHFFFAOYSA-N		Interactions Focus chain D [auth C] Focus chain E [auth C] Focus chain F [auth A] Focus chain H [auth B] Interactions & Density Focus chain D [auth C] Focus chain E [auth C] Focus chain F [auth A] Focus chain H [auth B]
A1I1I (Subject of Investigation/LOI) Query on A1I1I Download:Ideal Coordinates CCD File SDF format, chain I [auth B] SDF format, chain G [auth A] MOL2 format, chain I [auth B] MOL2 format, chain G [auth A] mmCIF format, chain I [auth B] mmCIF format, chain G [auth A]	G [auth A], I [auth B]	4-[4-[4-[[(6~{a}~{S})-2-methoxy-11-oxidanylidene-6~{a},7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]phenyl]-~{N}-(1-benzothiophen-5-yl)-1-methyl-pyrrole-2-carboxamide C₃₇ H₃₅ N₅ O₅ S RHYKGQSILIHTTJ-UHFFFAOYSA-N		Interactions Focus chain G [auth A] Focus chain I [auth B] Interactions & Density Focus chain G [auth A] Focus chain I [auth B]